South Africa Clinical Trial Supplies Market Size & Outlook
South Africa clinical trial supplies market, 2018-2030 (US$M)
Related Markets
South Africa clinical trial supplies market highlights
- The South Africa clinical trial supplies market generated a revenue of USD 13.6 million in 2023 and is expected to reach USD 18.3 million by 2030.
- The South Africa market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Clinical trial supplies market data book summary
| Market revenue in 2023 | USD 13.6 million |
| Market revenue in 2030 | USD 18.3 million |
| Growth rate | 4.3% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
| Key market players worldwide | Almac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.5% of the global clinical trial supplies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa clinical trial supplies market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 9.9 million by 2030.
Phase iii was the largest segment with a revenue share of 52.94% in 2023. Horizon Databook has segmented the South Africa clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa is one of the lucrative countries for conducting clinical trials by multinational biopharmaceutical companies. Presence of well-established research industry, which complies with International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) and FDA standards and diverse population as well as low cost of trials are expected to be some of the primary drivers of the market.
There were more than 2,200 clinical trials registered in South Africa as of 2017, majorly for HIV and tuberculosis. The high number of clinical trials can be attributed to the presence of highest number of doctors in public sector and improved infrastructure.
Clinical trial supplies players require an import license and an invoice approved by Medicine Control Council and this process may take up to 6 weeks. Companies such as Fisher Clinical Services and PAREXEL International Corporation have ventured into South Africa to cater to the increasing number of trials being conducted in the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa clinical trial supplies market size, by phase, 2018-2030 (US$M)
South Africa Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
